Back to Screener

Basic Materials

Kraig Biocraft Laboratories, Inc.(KBLB)

Live Price

Offline

$0.11

+0.00% today

1Y Change

+25.00%

Window

Jun 26, 2025 โ†’ Jun 24, 2026

Market Cap
$160.00M
Revenue Growth
0.0%
EPS Growth
-3.0%
Dividend Yield
0.0%

Coverage: 250 bars ยท Jun 26, 2025 โ†’ Jun 24, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Kraig Biocraft Laboratories, Inc. (KBLB) is a Basic Materials stock with a market cap of $160.00M and listed on OTC. The stock last traded around $0.11 and up 25.0% across the available one-year price window (Jun 26, 2025 โ†’ Jun 24, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of -3.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS -3.0%, free cash flow -97343777.3% with operating margin 0.0% and ROIC 0.0%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines KBLB price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Basic Materials peers on this page.

Sector Context

How this name stacks up against nearby peers on first-pass metrics.

Revenue Growth

Near sector median

0.0% vs 0.0% peer median

Operating Margin

Below sector median

0.0% vs +10.5% peer median

What Changed This Quarter

Latest report context and the signals most likely to have changed the story.

Latest report is on the board

2026 was reported on May 13, 2026, but the surprise data is still limited.

The operating picture looks softer than before

Revenue is at 0.0% and EPS is at -3.0%, with operating margin around 0.0%.

Earnings Reaction Memory

How the stock has tended to move after recent reports.

Across the last 3 reported quarters, the stock averaged -5.2% over the next 5 trading days and finished higher after 0 of those reports.

View quarter-by-quarter reaction table
QuarterEPS ฮ”1D5D20D
2026
May 13, 2026
โ€”+0.0%-7.1%-14.3%
2026
Mar 26, 2026
โ€”+0.0%-8.3%+25.0%
2025
Nov 11, 2025
โ€”+0.0%+0.0%+0.0%

Benchmark Edge

KBLB vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

KBLB

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

KBLB Max Drawdown

-37.50%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for KBLB and SPY.

Calendar-year return history is still loading or unavailable.
Kraig Biocraft Laboratories, Inc. logo

Company Overview

Kraig Biocraft Laboratories, Inc.

Other OTC

Ann Arbor, MI, US
Visit kraiglabs.comCall IR734 619 8066

Kraig Biocraft Laboratories, Inc. engages in developing protein-based fibers using recombinant DNA technology for commercial applications in the technical textile and specialty fiber industries in the United States. The company's products are used in military and police applications for ballistic protection; industrial applications, including critical cables and abrasion/impact resistant components; safety equipment; and composite materials for the aero-space industry. Its products are also used in various markets, such as medical textiles, geotextiles, defense and military textiles, safe and protective clothing, filtration textiles, composites with textile structure, and functional and sportive textiles, as well as textiles used in buildings and transportation. The company was incorporated in 2006 and is headquartered in Ann Arbor, Michigan.

Leadership
Kim Kraig Thompson
IPO Date
Apr 16, 2008
Employees
37
Street Address
2723 South State Street
Mailing
Ann Arbor, MI, 48104
Region
Ann Arbor, MI, US
Reporting Currency
USD
Investor Line
734 619 8066
Last Updated
May 1, 2026
CIK: 0001413119ISIN: US50075W1045CUSIP: 50075W104
Reports in USDSEC Registered

Key Fundamentals

Valuation, growth, profitability, and balance sheet signals.

Valuation

P/E
โ€”
EV/EBITDA
534730.4
Price/Sales
โ€”
Price/Book
โ€”

Growth

Revenue
0.0%
EPS
-3.0%
Free Cash Flow
-97343777.3%

Profitability

Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
44.0%
ROIC
0.0%

Balance Sheet

Debt/Equity
โ€”
Current Ratio
0.18

Earnings Reports

๐Ÿ“… Last reportedMay 13, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”
โ€”
May 13, 26
โ€”
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Mar 26, 26
0.00
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Nov 11, 25
-0.00
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Aug 18, 25
-0.00
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
May 12, 25
-0.00
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Mar 31, 25
-0.00
Est โ€”
โ€”
26.9B
Est โ€”
โ€”
โ€”
Nov 13, 24
-0.00
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Aug 14, 24
-0.00
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
May 14, 24
-0.00
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Apr 1, 24
-0.00
Est โ€”
โ€”
40.1B
Est โ€”
โ€”
โ€”
Nov 13, 23
-0.00
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Aug 14, 23
-0.00
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
May 12, 23
-0.00
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Mar 29, 23
-0.00
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Nov 14, 22
-0.00
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
โ€”
Aug 1, 22
-0.00
Est โ€”
โ€”
โ€”
Est โ€”
โ€”

Latest News

No news articles available

Official Releases

Company announcements and filings-style updates.

Official
No official releases available

Next Step

Keep the research moving

After the overview, the strongest next step is usually chart context or a tighter compare set.

Explore the advanced chart guideRead how to compare stocks